CRYSTALLINE SALT FORM OF (S)-(2-(6-CHLORO-7-METHYL-1H-BENZODIMIDAZOL-2-YL)-2-METHYLPYRROLIDIN-1-YL)(5-METHOXY-2-(2H-1,2,3-TRIAZOL-2-YL)PHENYL)METHANONE AS OREXIN RECEPTOR ANTAGONIST

摘要

The present invention relates to the use of (S) - (2- (6-chloro-7-methyl-1H- benzo [d] imidazol-2-yl) -2- methylpyrrolidin- The present invention relates to a crystalline form of 2- (2H-1,2,3-triazol-2-yl) phenyl) methanone hydrochloride, a process for producing the same, a pharmaceutical composition containing the crystalline form, and a medicament for the use thereof as an orexin receptor antagonist .